Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
The Woodlands, TX
SEC filing record 1 source field available
Fiscal year end
31 December
LEXICON PHARMACEUTICALS, INC. has filed 1,396 SEC EDGAR filings since 09 Feb 2000

SEC filing history

Showing 501-525 of 994 matching filings.

Per page
25
Current page
21
4

PRIMARY DOCUMENT

Filing date
29 Apr 2019
Reporting date
26 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2019
Reporting date
26 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2019
Reporting date
26 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-30111

CT ORDER filing

Filing date
29 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K

Filing date
26 Apr 2019
Reporting date
25 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-30111

DEFA 14A

Filing date
15 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-30111

DEF 14A

Filing date
15 Mar 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K

Filing date
13 Mar 2019
Reporting date
13 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-30111

PRE 14A

Filing date
15 Feb 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60409

LEXICON PHARMACEUTICALS FILING

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60409

SC 13G/A filing

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Feb 2019
Reporting date
07 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Feb 2019
Reporting date
07 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Feb 2019
Reporting date
07 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Feb 2019
Reporting date
07 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Feb 2019
Reporting date
07 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Feb 2019
Reporting date
07 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .